. Author manuscript; available in PMC: 2018 Sep 6.

Published in final edited form as: Am J Ophthalmol. 2015 Mar 11;159(6):1115–1122.e1. doi: 10.1016/j.ajo.2015.01.037

Table 4.

Age-stratified Prevalence of Intermediate-Stage Age-related Macular Degeneration in Participants in the Longitudinal Study of the Ocular Complications of AIDS vs the Beaver Dam Offspring Study

	LSOCA^*		Beaver Dam Offspring Study^†
Age (years)	Number participants	% with AMD^‡	Number participants	% with AMD^‡
21–34	244	5.3	168	0.6
35–44	782	5.9	822	1.3
45–54	605	12.9	1047	3.0
55–64	150	21.3	599	5.7
65–84	29	34.5	174	9.2
Total	1810	9.9	2810	3.3
Adjusted prevalences
Age-adjusted		12.1		2.9
Age- and gender-adjusted		13.0		3.2
Age- and gender-adjusted, whites only		11.4		3.3

LSOCA = Longitudinal Study of the Ocular Complications of AIDS. Excludes 15 participants age ≤20 years, as this age group was not evaluated in the Beaver Dam Offspring Study.

^†

Data from reference 21, Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors Arch Ophthalmol 2012;128:750–758.

^‡

AMD = age-related macular degeneration; % with intermediate-stage AMD reported.